[HTML][HTML] Role of p53 in breast cancer progression: An insight into p53 targeted therapy
C Marvalim, A Datta, SC Lee - Theranostics, 2023 - ncbi.nlm.nih.gov
The transcription factor p53 is an important regulator of a multitude of cellular processes. In
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …
the presence of genotoxic stress, p53 is activated to facilitate DNA repair, cell cycle arrest …
Natural product interventions for chemotherapy and radiotherapy-induced side effects
QY Zhang, FX Wang, KK Jia, LD Kong - Frontiers in pharmacology, 2018 - frontiersin.org
Cancer is the second leading cause of death in the world. Chemotherapy and radiotherapy
are the common cancer treatments. However, the development of adverse effects resulting …
are the common cancer treatments. However, the development of adverse effects resulting …
Traditional use, phytochemistry, toxicology, and pharmacology of Origanum majorana L.
A Bouyahya, I Chamkhi, T Benali… - Journal of …, 2021 - Elsevier
Ethnopharmacological relevance Origanum majorana L., is an aromatic and medicinal plant
distributed in different parts of Mediterranean countries. This species is widely used in …
distributed in different parts of Mediterranean countries. This species is widely used in …
Early diagnostic value of survivin and its alternative splice variants in breast cancer
S Khan, HF Bennit, D Turay, M Perez, S Mirshahidi… - BMC cancer, 2014 - Springer
Background The inhibitor of apoptosis (IAP) protein Survivin and its splice variants are
differentially expressed in breast cancer tissues. Our previous work showed Survivin is …
differentially expressed in breast cancer tissues. Our previous work showed Survivin is …
Molecular mechanism of anti-cancer activity of phycocyanin in triple-negative breast cancer cells
M Ravi, S Tentu, G Baskar, S Rohan Prasad… - BMC cancer, 2015 - Springer
Background Triple-negative breast cancers represent an important clinical challenge, as
these cancers do not respond to conventional endocrine therapies or other available …
these cancers do not respond to conventional endocrine therapies or other available …
[HTML][HTML] Natural products targeting the p53-MDM2 pathway and mutant p53: recent advances and implications in cancer medicine
The p53 tumor suppressor plays a major role in controlling the initiation and development of
cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 …
cancer by regulating cell cycle arrest, apoptosis, senescence, and DNA repair. The MDM2 …
Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy
XF Zhang, S Gurunathan - International journal of nanomedicine, 2016 - Taylor & Francis
Ovarian cancer is one of the most important malignancies, and the origin, detection, and
pathogenesis of epithelial ovarian cancer remain elusive. Although many cancer drugs have …
pathogenesis of epithelial ovarian cancer remain elusive. Although many cancer drugs have …
Carnosol induces ROS-mediated beclin1-independent autophagy and apoptosis in triple negative breast cancer
Background In this study we investigated the in vitro and in vivo anticancer effect of carnosol,
a naturally occurring polyphenol, in triple negative breast cancer. Results We found that …
a naturally occurring polyphenol, in triple negative breast cancer. Results We found that …
Origanum majorana Essential Oil Triggers p38 MAPK-Mediated Protective Autophagy, Apoptosis, and Caspase-Dependent Cleavage of P70S6K in Colorectal …
K Athamneh, A Alneyadi, H Alsamri, A Alrashedi… - Biomolecules, 2020 - mdpi.com
Colorectal cancer (CRC) is the third most common type of cancer in terms of incidence and
mortality worldwide. Here we have investigated the anti-colon cancer potential of Origanum …
mortality worldwide. Here we have investigated the anti-colon cancer potential of Origanum …